SEARCH

SEARCH BY CITATION

References

  • 1
    Bhandari R, Xiao J, Shankar A. Urinary bisphenol A and obesity in US children. Am J Epidemiol 2013;177:12631270.
  • 2
    Trasande L, Attina TM, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 2012;308:1113-1121.
  • 3
    Newbold RR, Padilla-Banks E, Jefferson WN. Environmental estrogens and obesity. Mol Cell Endocrinol 2009;304:84-89.
  • 4
    Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN. Developmental exposure to estrogenic compounds and obesity. Birth Defects Res A: Clin Mol Teratol 2005;73:478-480.
  • 5
    Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN. Perinatal exposure to environmental estrogens and the development of obesity. Mol Nutr Food Res 2007;51:912-917.
  • 6
    Werner Fürst R, Pistek VL, Kliem H, et al. Maternal low-dose estradiol-17β exposure during pregnancy impairs postnatal progeny weight development and body composition. Toxicol Appl Pharmacol 2012;263:338-344.
  • 7
    Hatch E, Troisi R, Palmer J, et al. Prenatal exposure to diethylstilbestrol and obesity in middle-aged women. In: Society of Epidemiologic Research; 2013 June 18–21; Boston, MA.
  • 8
    Christin-Maitre S. History of oral contraceptive drugs and their use worldwide. Best Pract Res Clin Endocrinol Metab 2013;27:3-12.
  • 9
    Smith OW. Diethylstilbestrol in the prevention and treatment of complications of pregnancy. Am J Obstet Gynecol 1948;56:821-834.
  • 10
    Bastos Sales L, Kamstra JH, Cenijn PH, van Rijt LS, Hamers T, Legler J. Effects of endocrine disrupting chemicals on in vitro global DNA methylation and adipocyte differentiation. Toxicol In Vitro 2013;27:1634-1643.
  • 11
    Hao CJ, Cheng XJ, Xia HF, Ma X. The endocrine disruptor diethylstilbestrol induces adipocyte differentiation and promotes obesity in mice. Toxicol Appl Pharmacol 2012;263:102-110.
  • 12
    Newbold RR. Prenatal exposure to diethylstilbestrol (DES). Fertil Steril 2008;89(2 Suppl):e55-e56.
  • 13
    Poissonnet CM, Burdi AR, Garn SM. The chronology of adipose tissue appearance and distribution in the human fetus. Early Hum Dev 1984;10:1-11.
  • 14
    Niswander KR, Gordon M, Collaborative Perinatal Project (U.S.), National Institute of Neurological Diseases and Stroke. The women and their pregnancies [by] Kenneth R. Niswander [and] Myron Gordon, with Heinz W. Berendes [et al.]. Saunders: Philadelphia; 1972.
  • 15
    Rich DQ, Zareba W, Beckett W, et al. Are ambient ultrafine, accumulation mode, and fine particles associated with adverse cardiac responses in patients undergoing cardiac rehabilitation? Environ Health Perspect 2012;120:1162-1169.
  • 16
    Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd edn. Wolters Kluwer Health/Lippincott Williams & Wilkins: Philadelphia; 2008.
  • 17
    Ross Z, Ito K, Johnson S, et al. Spatial and temporal estimation of air pollutants in New York City: exposure assignment for use in a birth outcomes study. Environ Health 2013;12: 51.
  • 18
    Collaborative Perinatal Project (U.S.), National Institute of Neurological Diseases and Blindness. Perinatal Research Branch. Medical Literature Services., National Institute of Neurological Diseases and Stroke. Perinatal Research Branch. Medical Literature Unit. Bibliography: the collaborative study on cerebral palsy, mental retardation, and other neurological and sensory disorders of infancy and childhood. In: DHEW Publication No (NIH) 72-117. U. S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health: Bethesda, MD. p 5 no.
  • 19
    Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11 2002;(246):1-190.
  • 20
    Axmon A, Rylander L, Albin M, Hagmar L. Factors affecting time to pregnancy. Hum Reprod 2006;21:1279-1284.
  • 21
    Mutsaerts MA, Groen H, Huiting HG, et al. The influence of maternal and paternal factors on time to pregnancy—a Dutch population-based birth-cohort study: the GECKO Drenthe study. Hum Reprod 2012;27:583-593.
  • 22
    Hall KS, Trussell J. Types of combined oral contraceptives used by US women. Contraception 2012;86:659-665.
  • 23
    Weden MM, Brownell P, Rendall MS. Prenatal, perinatal, early life, and sociodemographic factors underlying racial differences in the likelihood of high body mass index in early childhood. Am J Public Health 2012;102:2057-2067.
  • 24
    Catalano PM, Ehrenberg HM. The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG 2006;113:1126-1133.
  • 25
    Edelman AB, Carlson NE, Cherala G, et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception 2009;80:119-127.
  • 26
    Oken E, Levitan EB, Gillman MW. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes (Lond) 2008;32:201-210.
  • 27
    Reynolds RM, Osmond C, Phillips DI, Godfrey KM. Maternal BMI, parity, and pregnancy weight gain: influences on offspring adiposity in young adulthood. J Clin Endocrinol Metab 2010;95:5365-5369.
  • 28
    Stokes ME, Davis CS, Koch GG. Categorical Data Analysis Using the SAS System, 2nd edn. SAS Institute: Cary, NC, 2000.
  • 29
    Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998;78:783-809.
  • 30
    Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology 2000;141:649-656.
  • 31
    Janesick A, Blumberg B. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today 2011;93:34-50.
  • 32
    Hoover RN, Hyer M, Pfeiffer RM, et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 2011;365:1304-1314.
  • 33
    Palmer JR, Herbst AL, Noller KL, et al. Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health 2009;8:37.
  • 34
    Waller DK, Gallaway MS, Taylor LG, et al. Use of oral contraceptives in pregnancy and major structural birth defects in offspring. Epidemiology 2010;21:232-239.
  • 35
    Troisi R, Hyer M, Hatch EE, et al. Medical conditions among adult offspring prenatally exposed to diethylstilbestrol. Epidemiology 2013;24:430-438.
  • 36
    Ryan KK, Haller AM, Sorrell JE, Woods SC, Jandacek RJ, Seeley RJ. Perinatal exposure to bisphenol-a and the development of metabolic syndrome in CD-1 mice. Endocrinology 2010;151:2603-2612.
  • 37
    Hunter DJ, Manson JE, Colditz GA, et al. Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women. Contraception 1997;56:373-378.
  • 38
    Nischan P, Ebeling K, Thomas DB, Hirsch U. Comparison of recalled and validated oral contraceptive histories. Am J Epidemiol 1993;138:697-703.
  • 39
    Freedman DS, Sherry B. The validity of BMI as an indicator of body fatness and risk among children. Pediatrics 2009;124(Suppl 1):S23-34.
  • 40
    Smith AH, Bates MN. Confidence limit analyses should replace power calculations in the interpretation of epidemiologic studies. Epidemiology 1992;3:449-452.